SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (9083)9/14/2006 7:50:53 AM
From: Harold Engstrom  Read Replies (1) of 10345
 
ELN should be included in future B-school curricula on how to NOT to deal with a crisis.

I might disagree depending on what specifically you are referring to... (for example, which of the several crises...? <g>)

Generally, the choice to withdraw Tysabri was not made by Elan but rather by the FDA and Biogen. Managements previous efforts to divest products were done to good effect: great prices were obtained and enough left to provide a basis for operating at EBIDA breakeven. Currently, Tysabri launch seems to be going well. I am assuming that between US and EU about 1K scripts are being written every week and nothing I have heard would contradict that.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News